These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30485497)

  • 1. Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy.
    Ljunggren HG; Jonsson R; Höglund P
    Scand J Immunol; 2018 Dec; 88(6):e12731. PubMed ID: 30485497
    [No Abstract]   [Full Text] [Related]  

  • 2. Nobel notes value of basic research for new drugs.
    Krummel M
    Nature; 2018 Nov; 563(7730):184. PubMed ID: 30405221
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer immunologists scoop medicine Nobel prize.
    Ledford H; Else H; Warren M
    Nature; 2018 Oct; 562(7725):20-21. PubMed ID: 30279600
    [No Abstract]   [Full Text] [Related]  

  • 4. Embracing the complexity in cancer therapy.
    The Lancet Haematology
    Lancet Haematol; 2018 Nov; 5(11):e493. PubMed ID: 30389029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Caux C; Bay JO
    Bull Cancer; 2018 Dec; 105 Suppl 1():S1-S2. PubMed ID: 30595190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibitors win the 2018 Nobel Prize.
    Huang PW; Chang JW
    Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
    Teillaud JL
    Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 9. Hiding in Plain Sight: Soluble Immunomodulatory Receptors.
    Dahal LN; Schwarz H; Ward FJ
    Trends Immunol; 2018 Oct; 39(10):771-774. PubMed ID: 30195467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Era of Immune Checkpoint Therapy: From Cancer to Viral Infection-A Mini Comment on the 2018 Medicine Nobel Prize.
    Liu J; Pan W; Yang D
    Virol Sin; 2018 Dec; 33(6):467-471. PubMed ID: 30570713
    [No Abstract]   [Full Text] [Related]  

  • 11. New checkpoints in cancer immunotherapy.
    Ni L; Dong C
    Immunol Rev; 2017 Mar; 276(1):52-65. PubMed ID: 28258699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy comes of age and looks for maturity.
    Finck A; Gill SI; June CH
    Nat Commun; 2020 Jul; 11(1):3325. PubMed ID: 32620755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology beats cancer: a blueprint for successful translation.
    Pardoll DM
    Nat Immunol; 2012 Dec; 13(12):1129-32. PubMed ID: 23160205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors.
    Dammeijer F; Lau SP; van Eijck CHJ; van der Burg SH; Aerts JGJV
    Cytokine Growth Factor Rev; 2017 Aug; 36():5-15. PubMed ID: 28693973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint blockade therapy: the 2014 Tang Prize in Biopharmaceutical Science.
    Chen YS; Shen CR
    Biomed J; 2015; 38(1):5-8. PubMed ID: 25673064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
    Dougall WC; Kurtulus S; Smyth MJ; Anderson AC
    Immunol Rev; 2017 Mar; 276(1):112-120. PubMed ID: 28258695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer treatment: The killer within.
    Ledford H
    Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
    Furness AJ; Quezada SA; Peggs KS
    Immunotherapy; 2016 Jun; 8(7):763-6. PubMed ID: 27349975
    [No Abstract]   [Full Text] [Related]  

  • 19. Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize.
    Castelo-Branco L; Silva IP; Canhão H; Awada A
    Acta Med Port; 2019 Apr; 32(4):251-257. PubMed ID: 31067417
    [No Abstract]   [Full Text] [Related]  

  • 20. Coinhibitory Pathways in Immunotherapy for Cancer.
    Baumeister SH; Freeman GJ; Dranoff G; Sharpe AH
    Annu Rev Immunol; 2016 May; 34():539-73. PubMed ID: 26927206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.